Latest Breaking News On - Sugawara clinic - Page 1 : comparemela.com

Japan: A recent study published in Diabetes Therapy has shown the efficacy of luseogliflozin (SGLT2 inhibitor) over DPP-4 inhibitors in the mid/long-term, irrespective of BMI or age.The study revealed.

Masahiro sugawaraSugawara clinicDiabetes therapyDipeptidyl peptidase 4 inhibitorEstimated glomerular filtration rateType 2 diabetesSodium glucose cotransporter 2 inhibitorSystolic blood pressureGlycated hemoglobinPulse rate